Mark Carthy insider trades: Cyberkinetics Neurotechnology Systems (CYKN) stock purchases
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Mark reports to the SEC
Open-market buys and sales
6 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Oct 18, 2006 | CYKN | ↑ Buy | 833,334 | $1.20 | $1.0M | Direct | Oct 20, 2006 (2d) |
| Oct 17, 2006 | TRBN | ↑ Buy | 41,614 | $13.00 | $541K | Direct | Oct 19, 2006 (2d) |
| Sep 26, 2005 | CYKN | ↑ Buy | 2,475,166 | $1.20 | $3.0M | Direct | Sep 28, 2005 (2d) |
| Sep 26, 2005 | CYKN | ↑ Buy | 24,834 | $1.20 | $30K | By mRNA Fund II L.P. | Sep 28, 2005 (2d) |
| Jul 12, 2005 | SLXA | ↑ Buy | 544,536 | $4.00 | $2.2M | Direct | Jul 14, 2005 (2d) |
| Jul 12, 2005 | SLXA | ↑ Buy | 5,464 | $4.00 | $22K | By mRNA Fund II L.P. | Jul 14, 2005 (2d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Mark Carthy's insider trades
Mark Carthy is a director at Cyberkinetics Neurotechnology Systems (CYKN). Since Jul 12, 2005, Mark has reported 6 open-market purchases worth $6.7M and no sales on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include grants and awards (7 filings), other transactions (4 filings), conversions (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every CYKN insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.